Inventor · disambiguated record
Megan D. Hoban
Also filed as: HOBAN MEGAN · HOBAN MEGAN D · HOBAN MEGAN DANIELLE
2 granted patents·4 pending applications·2 citations·filing 2018–2021
45Inventor score
Top patents by PatentIndex Score
6 records- 0179US10434185B2Compositions and methods for the depletion of CD137+ cellsMAGENTA THERAPEUTICS INC·Filed 2018·Granted Oct 8, 2019·1 cites·29 claims
- 0275US10576161B2Compositions and methods for the depletion of CD137+ cellsMAGENTA THERAPEUTICS INC·Filed 2018·Granted Mar 3, 2020·1 cites·24 claims
- 0359US2020289664A1Compositions and methods for the depletion of cd137+ cellsMAGENTA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0448US2021101990A1Compositions and methods for the depletion of cd134+ cellsMAGENTA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0546US2024000847A1MethodsBLUEBIRD BIO INC·Filed 2021·Application pending·0 cites
- 0641US2021220408A1Aryl hydrocarbon receptor antagonists and methods of useMAGENTA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Megan D. Hoban files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →